Literature DB >> 16297188

Systematic linkage disequilibrium analysis of SLC12A8 at PSORS5 confirms a role in susceptibility to psoriasis vulgaris.

Ulrike Hüffmeier1, Jesús Lascorz, Heiko Traupe, Beate Böhm, Funda Schürmeier-Horst, Markward Ständer, Reinhard Kelsch, Claudia Baumann, Wolfgang Küster, Harald Burkhardt, André Reis.   

Abstract

The gene for solute carrier family 12 member A8 has recently been proposed as a candidate gene for psoriasis susceptibility (PSORS5) on chromosome 3q based on association of five single nucleotide polymorphisms (SNP) in Swedish patients. To investigate whether this locus is relevant for German psoriasis vulgaris (PsV) patients, we analyzed a group of 210 trios and a case-control group including 375 patients. Based on our investigation of the linkage disequilibrium (LD) structure of SLC12A8, we assayed 35 haplotype tag SNP and grouped them into nine LD-blocks. In the case-control study, we detected an association for six SNP and three LD-based haplotypes. Association was strongest for ss35527511 (chi2 = 11.224, p = 0.0008) and haplotype E-2 (chi2 = 11.788, p = 0.00059) and independent of the presence of an HLA-associated PSORS1 risk allele. Through extended haplotype analysis, we could show that two independent association signals exist in SLC12A8, suggesting allelic heterogeneity. None of the SNP showed association in trios, apart from a weak association of rs2228674 (transmission disequilibrium test statistics p = 0.048), probably due to insufficient power. We conclude that SLC12A8 is a susceptibility locus for PsV. In order to establish the exact nature of this association, efforts to identify the disease-causing variants are ongoing.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16297188     DOI: 10.1111/j.0022-202X.2005.23847.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  [Genetics of common chronic inflammatory skin diseases : An update on atopic dermatitis and psoriasis].

Authors:  E Rodríguez; K Eyerich; S Weidinger
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

2.  Early gene changes induced by isotretinoin in the skin provide clues to its mechanism of action.

Authors:  Amanda M Nelson; Wei Zhao; Kathryn L Gilliland; Andrea L Zaenglein; Wenlei Liu; Diane M Thiboutot
Journal:  Dermatoendocrinol       Date:  2009-03

3.  Evidence for susceptibility determinant(s) to psoriasis vulgaris in or near PTPN22 in German patients.

Authors:  U Hüffmeier; M Steffens; H Burkhardt; J Lascorz; F Schürmeier-Horst; M Ständer; R Kelsch; C Baumann; W Küster; R Mössner; K Reich; T F Wienker; H Traupe; A Reis
Journal:  J Med Genet       Date:  2005-12-09       Impact factor: 6.318

Review 4.  Psoriasis genetics: breaking the barrier.

Authors:  Elisha D O Roberson; Anne M Bowcock
Journal:  Trends Genet       Date:  2010-08-06       Impact factor: 11.639

5.  Genetics of psoriasis: a basis for precision medicine.

Authors:  Delin Ran; Minglong Cai; Xuejun Zhang
Journal:  Precis Clin Med       Date:  2019-06-24

6.  Identification of low-frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization.

Authors:  Beate Böhm; Harald Burkhardt; Steffen Uebe; Maria Apel; Frank Behrens; André Reis; Ulrike Hüffmeier
Journal:  Arthritis Res Ther       Date:  2012-04-18       Impact factor: 5.156

7.  A general linear model-based approach for inferring selection to climate.

Authors:  Srilakshmi M Raj; Luca Pagani; Irene Gallego Romero; Toomas Kivisild; William Amos
Journal:  BMC Genet       Date:  2013-09-22       Impact factor: 2.797

8.  Characterisation of psoriasis susceptibility locus 6 (PSORS6) in patients with early onset psoriasis and evidence for interaction with PSORS1.

Authors:  U Hüffmeier; J Lascorz; T Becker; F Schürmeier-Horst; A Magener; A B Ekici; S Endele; C T Thiel; S Thoma-Uszynski; R Mössner; K Reich; W Kurrat; T F Wienker; H Traupe; A Reis
Journal:  J Med Genet       Date:  2009-06-11       Impact factor: 6.318

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.